BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20869226)

  • 1. Costs of COPD exacerbations in the emergency department and inpatient setting.
    Dalal AA; Shah M; D'Souza AO; Rane P
    Respir Med; 2011 Mar; 105(3):454-60. PubMed ID: 20869226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of inpatient and emergency department care for chronic obstructive pulmonary disease in an elderly Medicare population.
    Dalal AA; Shah M; D'Souza AO; Rane P
    J Med Econ; 2010; 13(4):591-8. PubMed ID: 20854113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations].
    Jahnz-Rózyk K; Targowski T; From S; Płusa T
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():91-4. PubMed ID: 15524028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of COPD exacerbations: a university hospital--based study in Greece.
    Geitona M; Hatzikou M; Steiropoulos P; Alexopoulos EC; Bouros D
    Respir Med; 2011 Mar; 105(3):402-9. PubMed ID: 20970310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
    Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.
    Toy EL; Gallagher KF; Stanley EL; Swensen AR; Duh MS
    COPD; 2010 Jun; 7(3):214-28. PubMed ID: 20486821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing and applying a stochastic dynamic population model for chronic obstructive pulmonary disease.
    Hoogendoorn M; Rutten-van Mölken MP; Hoogenveen RT; Al MJ; Feenstra TL
    Value Health; 2011 Dec; 14(8):1039-47. PubMed ID: 22152172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitutive "hospital at home" versus inpatient care for elderly patients with exacerbations of chronic obstructive pulmonary disease: a prospective randomized, controlled trial.
    Aimonino Ricauda N; Tibaldi V; Leff B; Scarafiotti C; Marinello R; Zanocchi M; Molaschi M
    J Am Geriatr Soc; 2008 Mar; 56(3):493-500. PubMed ID: 18179503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system.
    Mittmann N; Kuramoto L; Seung SJ; Haddon JM; Bradley-Kennedy C; Fitzgerald JM
    Respir Med; 2008 Mar; 102(3):413-21. PubMed ID: 18086519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
    Jahnz-Różyk K; Targowski T; From S; Faluta T; Borowiec L
    Pneumonol Alergol Pol; 2011; 79(5):337-42. PubMed ID: 21861257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estimation of direct medical costs of chronic obstructive pulmonary disease over 12 months].
    Stâmbu I; Stoicescu IP
    Pneumologia; 2013; 62(2):86-92. PubMed ID: 23894789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments.
    Rowe BH; Villa-Roel C; Guttman A; Ross S; Mackey D; Sivilotti ML; Worster A; Stiell IG; Willis V; Borgundvaag B
    Acad Emerg Med; 2009 Apr; 16(4):316-24. PubMed ID: 19298621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPD: illness severity, resource utilisation and cost.
    Tynan AJ; Lane SJ
    Ir Med J; 2005 Feb; 98(2):41-2, 44-5. PubMed ID: 15835510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
    Fan VS; Ramsey SD; Make BJ; Martinez FJ
    COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
    Jahnz-Rózyk K; Targowski T; From S
    Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of exacerbations and admissions in chronic obstructive pulmonary disease].
    Arnedillo Muñoz A
    Arch Bronconeumol; 2010; 46 Suppl 8():8-14. PubMed ID: 21334550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.